510(k) Report

De Novo · Granted

Granted

Nephrocheck Test System

DEN130031De NovoGranted Sep 5, 2014457-day reviewClass II21 CFR 862.1220

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Astute Medical, Inc. · PIG Acute Kidney Injury Test System

Granted on Sep 5, 2014 as a new device type through De Novo after a 457-day review. 1 later device descends from it.

Decided
Sep 5, 2014
Review
457 days
Class
Class II
Product code
PIG
Recalls
None

1 later device descends from it, 1 citing it directly.

Descendants, by year cleared 2023: 1 descendant cleared2010201520202025
  1. This deviceDEN130031 Nephrocheck Test SystemAstute Medical, Inc. · 2014
  2. Descendant · cites it directly · 0 of its ownK232761 ProNephro AKI™ (NGAL)Bioporto Diagnostic, Inc. · 2023 · Recalled

Most influential descendants

Showing 1 of 1 · See all
  • K232761ProNephro AKI™ (NGAL)Bioporto Diagnostic, Inc. · 2023 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)DEN130031Nephrocheck Test SystemAstute Medical, Inc.2014—
+1K232761ProNephro AKI™ (NGAL)Bioporto Diagnostic, Inc.20231

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202310
FIG. 1 — Lineage of DEN130031, 2014–2023Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA De Novo database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in PIG? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new PIG device

  1. #1 K232761 ProNephro AKI™ (NGAL)score 4.5 · 1 generation · no Class I recall
  2. #2 Held for the reportin the report
Get a 510(k) Report

Does it have a predicate?

De Novo decisions do not claim a predicate device.

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K232761ProNephro AKI™ (NGAL)Bioporto Diagnostic, Inc.20230

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K232761 (Bioporto Diagnostic, Inc., 2023) has gone furthest, with 0 descendants of its own.

How does its category compare?

All PIG devices

PIG Acute Kidney Injury Test System: FDA decisions, review times, recalls and adverse event reports over 20 years. 2014, this device’s year, is highlighted.

FDA decisions per year · PIG

1in 2023

2014: 12016: 12017: 12022: 12023: 1
2007high 1 (2014) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · PIG

Too few PIG 510(k)s in any year since 2007 to give a median.

Recalls per year · PIG

1so far in 2026, the most since 2007

2026 (partial year): 1
2007high 1 (2026) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · PIG

1in 2024

2024: 1
2007high 1 (2024) · low 0 (2007)2025

MAUDE reports naming product code PIG, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20130—00
20141—00
20150—00
20161—00
20171—00
20180—00
20190—00
20200—00
20210—00
20221—00
20231—00
20240—01
20250—00
20260—1—

What is it indicated for?

The Astute Medical NEPHROCHECK® Test System is intended to be used in conjunction with clinical evaluation in patients who currently have or have had within the past 24 hours acute cardiovascular and or respiratory compromise and are ICU patients as an aid in the risk assessment for moderate or severe acute kidney injury (AKI) within 12 hours of patient assessment. The NEPHROCHECK® Test System is intended to be used in patients 21 years of age or older.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “DEN130031: Nephrocheck Test System.” Lineage record from FDA De Novo data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/DEN130031

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026